DOCSLIB.ORG

Hyperkinetic Movement Disorders Differential Diagnosis and Treatment

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hyperkinetic Movement Disorders Differential Diagnosis and Treatment Hyperkinetic Movement Disorders Differential diagnosis and treatment Albanese_ffirs.indd i 1/23/2012 10:47:45 AM Wiley Desktop Edition This book gives you free access to a Wiley Desktop Edition – a digital, interactive version of your book available on your PC, Mac, laptop or Apple mobile device. To access your Wiley Desktop Edition: • Find the redemption code on the inside front cover of this book and carefully scratch away the top coating of the label. • Visit “http://www.vitalsource.com/software/bookshelf/downloads” to download the Bookshelf application. • Open the Bookshelf application on your computer and register for an account. • Follow the registration process and enter your redemption code to download your digital book. • For full access instructions, visit “http://www.wiley.com/go/albanese/movement” Companion Web Site A companion site with all the videos cited in this book can be found at: www.wiley.com/go/albanese/movement Albanese_ffirs.indd ii 1/23/2012 10:47:45 AM Hyperkinetic Movement Disorders Differential diagnosis and treatment EDITED BY Alberto Albanese MD Professor of Neurology Fondazione IRCCS Istituto Neurologico Carlo Besta Università Cattolica del Sacro Cuore, Milan, Italy Joseph Jankovic MD Professor of Neurology Director, Parkinson’s Disease Center and Movement Disorders Clinic Department of Neurology Baylor College of Medicine Houston, TX, USA A John Wiley & Sons, Ltd., Publication Albanese_ffirs.indd iii 1/23/2012 10:47:45 AM This edition first published 2012, © 2012 by Blackwell Publishing Ltd Blackwell Publishing was acquired by John Wiley & Sons in February 2007. Blackwell’s publishing program has been merged with Wiley’s global Scientific, Technical and Medical business to form Wiley-Blackwell. Registered Office John Wiley & Sons, Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK Editorial Offices 9600 Garsington Road, Oxford, OX4 2DQ, UK The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK 111 River Street, Hoboken, NJ 07030-5774, USA For details of our global editorial offices, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at www.wiley.com/ wiley-blackwell The right of the author to be identified as the author of this work has been asserted in accordance with the UK Copyright, Designs and Patents Act 1988. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act 1988, without the prior permission of the publisher. Designations used by companies to distinguish their products are often claimed as trademarks. All brand names and product names used in this book are trade names, service marks, trademarks or registered trademarks of their respective owners. The publisher is not associated with any product or vendor mentioned in this book. This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is sold on the understanding that the publisher is not engaged in rendering professional services. If professional advice or other expert assistance is required, the services of a competent professional should be sought. The contents of this work are intended to further general scientific research, understanding, and discussion only and are not intended and should not be relied upon as recommending or promoting a specific method, diagnosis, or treatment by physicians for any particular patient. The publisher and the author make no representations or warranties with respect to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without limitation any implied warranties of fitness for a particular purpose. In view of ongoing research, equipment modifications, changes in governmental regulations, and the constant flow of information relating to the use of medicines, equipment, and devices, the reader is urged to review and evaluate the information provided in the package insert or instructions for each medicine, equipment, or device for, among other things, any changes in the instructions or indication of usage and for added warnings and precautions. Readers should consult with a specialist where appropriate. The fact that an organization or Website is referred to in this work as a citation and/or a potential source of further information does not mean that the author or the publisher endorses the information the organization or Website may provide or recommendations it may make. Further, readers should be aware that Internet Websites listed in this work may have changed or disappeared between when this work was written and when it is read. No warranty may be created or extended by any promotional statements for this work. Neither the publisher nor the author shall be liable for any damages arising herefrom. Library of Congress Cataloging-in-Publication Data Hyperkinetic movement disorders : differential diagnosis and treatment / edited by Alberto Albanese, Joseph Jankovic. p. ; cm. Includes bibliographical references and index. ISBN-13: 978-1-4443-3352-7 (hard cover : alk. paper) ISBN-10: 1-4443-3352-6 (hard cover : alk. paper) ISBN-13: 978-1-4443-4615-2 (ePDF) ISBN-13: 978-1-4443-4618-3 (Wiley Online Library) [etc.] 1. Hyperkinesia. 2. Diagnosis, Differential. I. Albanese, Alberto. II. Jankovic, Joseph. [DNLM: 1. Hyperkinesis. 2. Movement Disorders. 3. Diagnosis, Differential. WL 390] RC376.5.H96 2012 616.85′89–dc23 2011020595 A catalogue record for this book is available from the British Library. Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic books. Set in 9/12pt Meridien by SPi Publisher Services, Pondicherry, India 1 2012 Albanese_ffirs.indd iv 1/23/2012 10:47:46 AM Contents Preface, vii List of Contributors, viii List of Videos, x Part 1 General Issues in Hyperkinetic Disorders, 1 1 Distinguishing Clinical Features of Hyperkinetic Disorders, 3 Alberto Albanese and Joseph Jankovic 2 Pathophysiology and Molecular Pathology of Dystonia and Tics, 15 Marie Vidailhet, Michael Schupbach, and David Grabli 3 Pathophysiology and Molecular Pathology of Tremor, Myoclonus, and Chorea, 26 Johannes D. Speelman, Elisabeth M. Foncke, Anne-Fleur van Rootselaar, and Marina A. Tijssen 4 Overview of the Medical Treatments of Hyperkinetic Disorders, 40 William Ondo 5 Overview of Surgical Treatment Possibilities in Hyperkinetic Disorders, 49 Vinata Vedam-Mai, Oscar Bernal, and Michael S. Okun Part 2 Tremor Syndromes, 71 6 Essential Tremor, 73 Julián Benito-León and Elan D. Louis 7 Other Tremors, 95 Claustre Pont-Sunyer, Eduardo Tolosa and Judith Navarro-Otano Part 3 Dystonia Syndromes, 113 8 Primary Dystonias, 115 Antonio E. Elia and Alberto Albanese 9 Secondary Dystonias, 135 Susanne A. Schneider Part 4 Chorea Syndromes, 147 10 Huntington Disease and Other Genetic Choreas, 149 Ainhi Ha and Joseph Jankovic v Albanese_ftoc.indd v 1/23/2012 10:59:08 AM vi Contents 11 Acquired Choreas, 175 Ruth H. Walker 12 Tics and Tourette Syndrome, 188 Joseph Jankovic 13 Secondary Tics, 200 Francisco Cardoso Part 5 Myoclonus Syndromes, 207 14 Inherited Myoclonus Syndromes, 209 Emmanuel Roze and Emmanuelle Apartis 15 Segmental Myoclonus, 221 John Nathaniel Caviness 16 Other Jerks and Startles, 236 Codrin Lungu and Mark Hallett Part 6 Ataxias, 257 17 Clinical and Pathophysiological Features of Cerebellar Dysfunction, 259 Giuliana Grimaldi and Mario Manto 18 Inherited and Sporadic Ataxias, 279 Hélio A.G. Teive, Renato P. Munhoz, and Tetsuo Ashizawa Part 7 Other Hyperkinetic Disorders, 297 19 Dyskinesias in Parkinsonian Syndromes, 299 S. Elizabeth Zauber and Christopher G. Goetz 20 Restless Legs Syndrome, 311 Pamela Hamilton-Stubbs and Arthur S. Walters 21 Tardive Dyskinesias, 331 Gonzalo J. Revuelta, Leslie Cloud, Pratibha G. Aia, and Stewart A. Factor 22 Stereotypies and Other Developmental Hyperkinesias, 353 Jayasri Srinivasan and Jonathan W. Mink 23 Paroxysmal Dyskinesias, 363 Miryam Carecchio, João Massano, and Kailash P. Bhatia 24 Psychogenic Movement Disorders, 375 Stanley Fahn Index, 385 A companion site with all the videos cited in this book can be found at: www.wiley.com/go/albanese/movement Albanese_ftoc.indd vi 1/23/2012 10:59:08 AM Preface Hyperkinetic movement disorders have always effective and safe medical and surgical treatment puzzled neurologists and other clinicians because of strategies. Appropriate diagnosis, however, is criti- uncertainties about their classification and treat- cal before the most suitable disease-specific treat- ment. At first sight, many hyperkinetic disorders ment is selected and offered to the patient. may look alike, but a closer examination of their Because of diagnostic challenges in the field of phenomenology, including pattern, rhythm, and hyperkinetic movement disorders many patients anatomic distribution, usually allows for their seek multiple opinions. These consultations are proper categorization. Although in general sometimes done informally and facilitated by neurology, clinical anatomical correlates are the exchanging patient videos. Personal experience cornerstone of diagnosis, in movement disorders and expert knowledge are perhaps more important phenomenology has an essential role. In our training in this field than other neurological disciplines.
Load more

Recommended publications
  • Anxiety Disorders of Childhood and Adolescence Jesse C
    Anxiety Disorders of Childhood and Adolescence Jesse C. Rhoads, DO & Craig L. Donnelly, MD 1. Background, EpidEmiology and rElEvancE Anxiety symptoms are ubiquitous in youth. Clinicians need to be familiar with the normal developmental course of anxieties in youth and their consequent mastery by children in order to differentiate normative versus pathological anxiety. Anxiety symptoms do not necessarily constitute an anxiety disorder. Fear and anxiety are common experiences across childhood and adolescence. The clinician evaluating childhood anxiety disorders faces the task of differentiating the normal, transient and developmentally appropriate expressions of anxiety from pathological anxiety. Adept assessment and management of anxiety symptoms through reassurance, anticipatory guidance and psychoeducation of parents may forestall the development of full blown anxiety syndromes. Anxiety disorders are among the most common psychiatric disorders in children and adolescents affecting from 7-15% of individuals under 18 years of age. Anxiety disorders are not rare and often mimic or are comorbid with other childhood disorders. Symptoms such as school refusal, tantrums, or irritability may be less reflective of oppositional behavior than an underlying social phobia or generalized anxiety disorder. Given the uniqueness of each child and the complex interplay among the internal and external variables that drive anxiety, a multimodal approach to diagnosis and treatment is warranted. Anxiety disorders are a heterogeneous group of disorders that vary in their etiology, treatment, and prognosis. Given these differences, we will discuss each condition individually to help the primary care clinician in parsing out the necessary details of each disorder. Separation anxiety disorder The estimated prevalence of SAD is 4-5%, making it one of the most common childhood psychiatric disorders.
    [Show full text]
  • Addison's Disease Elucidating PANDAS
    PRACTICE BUILDING Naturopathic Specialty Practice: Keys to NATUROPATHIC DOCTOR NEWS & REVIEW Making It Successful ..........................>>10 Darin Ingels, ND VOLUME 10 ISSUE 4 April 2014 | Autoimmune / ALLER gy Medicine Sometimes specialty practices happen by accident. A case study and some tips help pave the way for Tolle Causam success. TOLLE CAUSAM Autoimmunity and the Gut: Elucidating PANDAS How Intestinal Inflammation Contributes to Autoimmune Disease .....................>>12 Follow-Up Discussion of an Immune-Mediated Jenny Berg, ND, LAc Kelly Baker, ND, LAc Intestinal flora influences our immune system’s Mental Illness ability to differentiate self from non-self. Steven Rondeau, ND, BCIA-EEG VIS MEDICATRIX NATURAE Allergy Elimination Technique: Simplified ANDAS is an acronym for “Pediatric Treatment of Difficult Cases ..............>>15 PAutoimmune Neuropsychiatric Sheryl Wagner, ND Disorder Associated with Streptococcus.” A few case studies illustrate the surprisingly broad This condition, which was initially application of NAET with patients. identified by Sue Swedo, MD, and DOCERE described in the American Journal of Autoimmune Infertility in Women: Psychiatry in 1998,1 is characterized by Part 2 ...................................................>>16 abrupt-onset obsessive-compulsive Fiona McCulloch, BSc, ND disorder (OCD) and/or other Intestinal support, autoimmune diet, and neuropsychiatric symptoms in a child. (See nutraceuticals help reverse a common cause of Table 1 for Swedo’s original diagnostic female infertility. criteria.) In my previous NDNR paper NATUROpaTHIC NEWS from 2010,2 I described the presentation, history and controversy surrounding this Association Spotlight: An Introduction newly identified syndrome. Since that to the ANRI and NORI .........................>>20 time, several other groups have sought Colleen Huber, NMD to better redefine this condition, and the Dr Huber introduces ANRI & NORI, organizations committed to the advancement of research & acronym, PANS, or Pediatric Acute-Onset education on chronic disease.
    [Show full text]
  • Monosomy X Turner Syndrome Information for Patients
    Monosomy X Turner syndrome Information for patients The healthcare professional responsible for your care has given you this leaflet because you have been identified by the Harmony® Prenatal Test as having a high probability of a chromosome disorder in your pregnancy. This fact sheet contains more information about the particular genetic disorder mentioned in your Harmony report. We recommend that you also discuss your result with an experienced doctor or genetic counsellor. Turner syndrome, or Monosomy X, is a sex chromosome disorder that occurs in females when there is only one copy of the X chromosome instead of the expected two (Figure 1). It occurs in at least one in every 2,500 female births. Monosomy X may be associated with an increased risk of miscarriage in the first or second trimester. More than half of those withT urner syndrome will be mosaic, meaning some of their cells have just one X chromosome and the other cells have two X chromosomes. Features and symptoms of Turner syndrome include subtle changes in physical appearance, short stature, infertility and learning difficulties, as well as some potential health conditions, including cardiac conditions, hypothyroidism, diabetes and autoimmune disease. Babies who are born with Turner syndrome could have a number of the features and symptoms of the syndrome, however, not everyone will have them all and severity will vary significantly. Mosaicism also plays a role in the varied severity of the syndrome. Although there is no cure for Turner syndrome, many of the associated symptoms can be treated. Girls with Turner syndrome may need regular health checks of their heart, kidneys and reproductive system throughout their lives.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,381,189 B2 Green Et Al
    US009381189B2 (12) United States Patent (10) Patent No.: US 9,381,189 B2 Green et al. (45) Date of Patent: Jul. 5, 2016 (54) INGREDIENTS FOR INHALATION AND (56) References Cited METHODS FOR MAKING THE SAME U.S. PATENT DOCUMENTS (75) Inventors: Matthew Michael James Green, 4,582,265 A * 4/1986 Petronelli ....................... 241.95 Wiltshire (GB); Richard Michael Poole, 6,257,233 B1 7/2001 Burr et al. 2004/01 18007 A1* 6/2004 Chickering et al. ............ 34/360 Wiltshire (GB) 2006, O257491 A1* 11, 2006 Morton et al. ... 424/489 (73) Assignee: VECTURA LIMITED, Wiltshire (GB) 2008/0063719 A1 3/2008 Morton et al. ................ 424/489 (*) Notice: Subject to any disclaimer, the term of this FOREIGN PATENT DOCUMENTS patent is extended or adjusted under 35 EP O709086 A2 5, 1996 U.S.C. 154(b) by 641 days. EP 14981 16 A1 1, 2005 GB 2387781 A 10, 2003 JP 2005298.347 10/2005 (21) Appl. No.: 13/514,672 JP 200954.1393 11, 2009 JP 2012,542618 6, 2012 (22) PCT Fled: Dec. 8, 2010 WO 96.23485 A1 8, 1996 WO 9703649 A1 2, 1997 (86) PCT NO.: PCT/GB2O10/052053 WO O2OO197 A1 1, 2002 WO O243701 A2 6, 2002 S371 (c)(1), WO 2005105043 A2 11/2005 Aug. 20, 2012 WO 2007053904 A1 5/2007 (2), (4) Date: WO 2008.000482 1, 2008 (87) PCT Pub. No.: WO2O11AO70361 WO 2009095684 A1 8, 2009 OTHER PUBLICATIONS PCT Pub. Date: Jun. 16, 2011 Brunauer et al. "Adsorption of Gases in Multimolecular Layers'. J. (65) Prior Publication Data Am.
    [Show full text]
  • Complete Issue
    Conerete Bloek & Sprayed Coating-­ a ~inning eOlDbination of beauty & silDplieity at lo~eost STAND RD CREGO CK WITH CEMENT LE E COAT AND SPRAYED-ON TE U ED INISH COAT • JERRY GOFFE PHOTO RUST TRACTOR COMPANY ELLISON-HAWKINS-VOGT 6' BYRNES, P.A. ARCH ITECTS ·ENGINEERS K. L. HOUSE CONSTRUCTION CO. GENERAL CONTRACTOR KENNETH P. THOMPSON CO., INC. MASONRY CONTRACTOR BILL C. CARROLL CO., INC. SPRAYED COATING "'\ For our reoders I"~, we wish 1976 to \'\'~" be rhapsodic, • thriving, abundant and eudaemonic. , '~-I4 ""_ """""' .----"''''''v~J col: 18 no. 1 jan. - feb. 1976 • new mexico architecture As we begin another year of New Mexico Architecture, it is appropri­ ate to remind our readers of the contribution made to our financial stability by the advertisers. It is their support which makes possible the production of the magazine. To all of these fine people the "staff" says a most sincere thank­ you! Space in New Mexico Architecture o DOD as a Resource for on Energy Ethic 10 Beginning on page lOis an arti­ - By Anthony C. Antoniades, AI.A, AI.P. cle by Anthony C. Antoniades, AlA, AlP, Associate Professor of Archi­ tecture at the University of Texas at Arlington. Professor Antoniades taught architecture at the Universi­ ty of New Mexico before moving to Index to Advertisers 18 Texas. It was during those years in our state that he developed a strong interest in and knowledge of the architectural heritage of New Mexi­ ico. Three articles by Antoniades hove appeared previously in NMA­ November/December 1971, Septem­ ber/October 1973 and July/August 1974.
    [Show full text]
  • National Center for Toxicological Research
    National Center for Toxicological Research Annual Report Research Accomplishments and Plans FY 2015 – FY 2016 Page 0 of 193 Table of Contents Preface – William Slikker, Jr., Ph.D. ................................................................................... 3 NCTR Vision ......................................................................................................................... 7 NCTR Mission ...................................................................................................................... 7 NCTR Strategic Plan ............................................................................................................ 7 NCTR Organizational Structure .......................................................................................... 8 NCTR Location and Facilities .............................................................................................. 9 NCTR Advances Research Through Outreach and Collaboration ................................... 10 NCTR Global Outreach and Training Activities ............................................................... 12 Global Summit on Regulatory Science .................................................................................................12 Training Activities .................................................................................................................................14 NCTR Scientists – Leaders in the Research Community .................................................. 15 Science Advisory Board ...................................................................................................
    [Show full text]
  • Analyzing Cohesive Devices in the Students Narrative
    ANALYZING COHESIVE DEVICES IN THE STUDENTS NARRATIVE TEXT WRITTEN BASED ON FRONT OF THE CLASS MOVIE SCRIPT (A Descriptive Research at the Third Semester in Muhammadiyah University of Makassar ) A THESIS Submitted at the Fulfillment to Accomplish Sarjana Degree at Faculty of Teacher Training and Education Makassar Muhammadiyah University MARSELLA 10535661515 ENGLISH EDUCATION DEPARTMENT FACULTY OF TEACHER TRAINING AND EDUCATION MUHAMMADIYAH UNIVERSITY OF MAKASSAR 2020 Jalan Sultan Alauddin No. 259Makassar UNIVERSITAS MUHAMMADIYAH MAKASSAR Telp : 0411-860837/860132 (Fax) FAKULTAS KEGURUAN DAN ILMU PENDIDIKANEmail : [email protected] Web : www.fkp.unismuh.ac.id PRODI PENDIDIKAN BAHASA INGGRIS SURAT PERNYATAAN Saya yang bertandatangan di bawah ini: Nama : Marsella NIM : 10535 6615 15 Jurusan : Pendidikan Bahasa Inggris Judul Skripsi : Analyzing Cohesive Devices In The Students Narrative Text Written Based On Front Of The Class Movie Script Dengan ini menyatakan bahwa skripsi yang saya buat di depan Tim penguji adalah hasil karya saya sendiri bukan hasil ciptaan orang lain atau pun dibuatkan oleh siapa pun. Demikianlah pernyataan ini saya buat dengan sebenar-benarnya dan saya bersedia menerima sanksi apabila pernyataan ini tidak benar. Makassar, 2020 Yang Membuat Pernyataan Marsella Jalan Sultan Alauddin No. 259Makassar UNIVERSITAS MUHAMMADIYAH MAKASSAR Telp : 0411-860837/860132 (Fax) FAKULTAS KEGURUAN DAN ILMU PENDIDIKANEmail : [email protected] Web : www.fkp.unismuh.ac.id PRODI PENDIDIKAN BAHASA INGGRIS SURAT PERJANJIAN Saya yang bertandatangan di bawah ini: Nama : Marsella NIM : 10535 6615 15 Jurusan : Pendidikan Bahasa Inggris Fakultas : Keguruan dan Ilmu Pendidikan Dengan ini menyatakan perjanjian sebagai berikut: 1. Mulai dari penyusunan proposal sampai dengan selesainya skripsi saya, saya akan menyusun sendiri skripsi saya, tidak dibuatkan oleh siapa pun.
    [Show full text]
  • Chromosome 18
    Chromosome 18 Description Humans normally have 46 chromosomes in each cell, divided into 23 pairs. Two copies of chromosome 18, one copy inherited from each parent, form one of the pairs. Chromosome 18 spans about 78 million DNA building blocks (base pairs) and represents approximately 2.5 percent of the total DNA in cells. Identifying genes on each chromosome is an active area of genetic research. Because researchers use different approaches to predict the number of genes on each chromosome, the estimated number of genes varies. Chromosome 18 likely contains 200 to 300 genes that provide instructions for making proteins. These proteins perform a variety of different roles in the body. Health Conditions Related to Chromosomal Changes The following chromosomal conditions are associated with changes in the structure or number of copies of chromosome 18. Distal 18q deletion syndrome Distal 18q deletion syndrome occurs when a piece of the long (q) arm of chromosome 18 is missing. The term "distal" means that the missing piece (deletion) occurs near one end of the chromosome arm. The signs and symptoms of distal 18q deletion syndrome include delayed development and learning disabilities, short stature, weak muscle tone ( hypotonia), foot abnormalities, and a wide variety of other features. The deletion that causes distal 18q deletion syndrome can occur anywhere between a region called 18q21 and the end of the chromosome. The size of the deletion varies among affected individuals. The signs and symptoms of distal 18q deletion syndrome are thought to be related to the loss of multiple genes from this part of the long arm of chromosome 18.
    [Show full text]
  • Annual Report
    Greeks Helping Greeks ANNUAL REPORT 2019 About THI The Hellenic Initiative (THI) is a global, nonprofi t, secular institution mobilizing the Greek Diaspora and Philhellene community to support sustainable economic recovery and renewal for Greece and its people. Our programs address crisis relief through strong nonprofi t organizations, led by heroic Greeks that are serving their country. They also build capacity in a new generation of heroes, the business leaders and entrepreneurs with the skills and values to promote the long term growth of Hellas. THI Vision / Mission Statement Investing in the future of Greece through direct philanthropy and economic revitalization. We empower people to provide crisis relief, encourage entrepreneurs, and create jobs. We are The Hellenic Initiative (THI) – a global movement of the Greek Diaspora About the Cover Featuring the faces of our ReGeneration Interns. We, the members of the Executive Committee and the Board of Directors, wish to express to all of you, the supporters and friends of The Hellenic Initiative, our deepest gratitude for the trust and support you have given to our organization for the past seven years. Our mission is simple, to connect the Diaspora with Greece in ways which are valuable for Greece, and valuable for the Diaspora. One of the programs you will read about in this report is THI’s ReGeneration Program. In just 5 years since we launched ReGeneration, with the support of the Coca-Cola Co. and the Coca-Cola Foundation and 400 hiring partners, we have put over 1100 people to work in permanent well-paying jobs in Greece.
    [Show full text]
  • Management of Side Effects of Antipsychotics
    Management of side effects of antipsychotics Oliver Freudenreich, MD, FACLP Co-Director, MGH Schizophrenia Program www.mghcme.org Disclosures I have the following relevant financial relationship with a commercial interest to disclose (recipient SELF; content SCHIZOPHRENIA): • Alkermes – Consultant honoraria (Advisory Board) • Avanir – Research grant (to institution) • Janssen – Research grant (to institution), consultant honoraria (Advisory Board) • Neurocrine – Consultant honoraria (Advisory Board) • Novartis – Consultant honoraria • Otsuka – Research grant (to institution) • Roche – Consultant honoraria • Saladax – Research grant (to institution) • Elsevier – Honoraria (medical editing) • Global Medical Education – Honoraria (CME speaker and content developer) • Medscape – Honoraria (CME speaker) • Wolters-Kluwer – Royalties (content developer) • UpToDate – Royalties, honoraria (content developer and editor) • American Psychiatric Association – Consultant honoraria (SMI Adviser) www.mghcme.org Outline • Antipsychotic side effect summary • Critical side effect management – NMS – Cardiac side effects – Gastrointestinal side effects – Clozapine black box warnings • Routine side effect management – Metabolic side effects – Motor side effects – Prolactin elevation • The man-in-the-arena algorithm www.mghcme.org Receptor profile and side effects • Alpha-1 – Hypotension: slow titration • Dopamine-2 – Dystonia: prophylactic anticholinergic – Akathisia, parkinsonism, tardive dyskinesia – Hyperprolactinemia • Histamine-1 – Sedation – Weight gain
    [Show full text]
  • TAAR1 Activation Modulates Monoaminergic Neurotransmission, Preventing Hyperdopaminergic and Hypoglutamatergic Activity
    TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity Florent G. Revela, Jean-Luc Moreaua, Raul R. Gainetdinovb, Amyaouch Bradaiac, Tatyana D. Sotnikovab, Roland Morya, Sean Durkina, Katrin Groebke Zbindend, Roger Norcrossd, Claas A. Meyere, Veit Metzlera, Sylvie Chaboza, Laurence Ozmena, Gerhard Trubea, Bruno Pouzeta, Bernhard Bettlerf, Marc G. Carong, Joseph G. Wettsteina, and Marius C. Hoenera,1 aNeuroscience Research, dDiscovery Chemistry, and eDiscovery Technologies, Pharmaceuticals Division, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland; bDepartment of Neuroscience and Brain Technologies, Italian Institute of Technology, 16163 Genoa, Italy; cNeuroservice, Domaine de Saint-Hilaire, 13593 Aix-en-Provence, France; fDepartment of Biomedicine, Institute of Physiology, Pharmazentrum, University of Basel, CH-4056 Basel, Switzerland; and gDepartment of Cell Biology, Duke University Medical Center, Durham, NC 27710 Edited by Richard D. Palmiter, University of Washington, Seattle, WA, and approved March 31, 2011 (received for review February 24, 2011) The trace amine-associated receptor 1 (TAAR1), activated by en- sitive to the locomotor-stimulating effect of d-amphetamine dogenous metabolites of amino acids like the trace amines and show elevated striatal release of dopamine (DA), noradren- p-tyramine and β-phenylethylamine, has proven to be an impor- aline (NA), and serotonin [5-hydroxytryptamine (5-HT)] after a d-amphetamine challenge (10, 12). Furthermore, the spontaneous tant modulator of the dopaminergic system and is considered −/− firing rate of the VTA DA neurons is augmented in Taar1 mice, a promising target for the treatment of neuropsychiatric disorders. fi To decipher the brain functions of TAAR1, a selective TAAR1 ago- and only in WT mice does pTyr decrease this ring rate (10).
    [Show full text]
  • RD-Action Matchmaker – Summary of Disease Expertise Recorded Under
    Summary of disease expertise recorded via RD-ACTION Matchmaker under each Thematic Grouping and EURORDIS Members’ Thematic Grouping Thematic Reported expertise of those completing the EURORDIS Member perspectives on Grouping matchmaker under each heading Grouping RD Thematically Rare Bone Achondroplasia/Hypochondroplasia Achondroplasia Amelia skeletal dysplasia’s including Achondroplasia/Growth hormone cleidocranial dysostosis, arthrogryposis deficiency/MPS/Turner Brachydactyly chondrodysplasia punctate Fibrous dysplasia of bone Collagenopathy and oncologic disease such as Fibrodysplasia ossificans progressive Li-Fraumeni syndrome Osteogenesis imperfecta Congenital hand and fore-foot conditions Sterno Costo Clavicular Hyperostosis Disorders of Sex Development Duchenne Muscular Dystrophy Ehlers –Danlos syndrome Fibrodysplasia Ossificans Progressiva Growth disorders Hypoparathyroidism Hypophosphatemic rickets & Nutritional Rickets Hypophosphatasia Jeune’s syndrome Limb reduction defects Madelung disease Metabolic Osteoporosis Multiple Hereditary Exostoses Osteogenesis imperfecta Osteoporosis Paediatric Osteoporosis Paget’s disease Phocomelia Pseudohypoparathyroidism Radial dysplasia Skeletal dysplasia Thanatophoric dwarfism Ulna dysplasia Rare Cancer and Adrenocortical tumours Acute monoblastic leukaemia Tumours Carcinoid tumours Brain tumour Craniopharyngioma Colon cancer, familial nonpolyposis Embryonal tumours of CNS Craniopharyngioma Ependymoma Desmoid disease Epithelial thymic tumours in
    [Show full text]